Company Profile
Sector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericEmployees
18Website
www.cardiolrx.comCountry
🇨🇦 Canada
Rank #22
CRDL
$1.2808
+3.68% (24h)
Last updated: 1 second ago
Market Cap
$147.64M
Volume (24h)
285.99K
Last Close (7D)
$1.28
A clinical-stage Canadian biotech developing CardiolRx, a pharmaceutical-grade CBD formulation targeting recurrent pericarditis and heart failure — rare cardiac conditions with very limited treatment options.
52-Week Range